Stichting Gezondheidscentra Eindhoven (SGE) Smoking Cessation Innovation.

Phase 4

• Conditions: Smoking; tobacco use; 10024450

• Registration Number: NL-OMON36281
• Lead Sponsor: niversiteit Maastricht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 272

Inclusion Criteria

daily smoker
18 years of age or older

Exclusion Criteria

Contra-indications for the use of varenicline

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Prolonged absinence from smoking from week 9 through week 26. Exhaled carbon<br /><br>monoxide (CO) will be measured, CO-levels of <10ppm will be used as a biomarker<br /><br>of absinence.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Intervention costs per quitter<br /><br>Cost-effectiveness ratio<br /><br>Compliance with the use of varenicline</p><br>